0.8821USD9.000 SEK · STO-5.26%Mkt Cap: 16.67M USDP/E: —2d ago
Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.…
Promimic (STO: PRO) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 17 employees.
The shares were at 9.000 SEK on 20 November 2026, down 30.8% over 52 weeks. Its 52-week range is 7.700 SEK to 19.45 SEK: the price is 53.7% below the high and 16.9% above the low.
Its market capitalisation is 170.03M SEK.
Promimic reports return on equity of -14.8%, an operating margin of -19.1% and revenue up 6.4% year over year.
It holds more cash than debt, a net cash position of 19.80M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.